One drug comes out ahead in treating ear infections
The results of a large study indicate that of the two most frequently prescribed antibiotics for the treatment of acute otitis media (AOM) in children, one is significantly more effective than the other in eradicating Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis, the three most common bacterial pathogens that cause AOM. Alejandro Hoberman, MD, chief, Division of General Academic Pediatrics, Children?s Hospital of Pittsburgh, Pennsylvania, and lead investigator of the study, reported that 91% of the children treated with amoxicillin/potassium clavulanate (Augmentin ES-600, GlaxoSmithKline) extra-strength powder for oral suspension showed improvement or were cured at the end of treatment, compared to 81% of those treated with azithromycin (Zithromax, Pfizer). Hoberman presented the study findings at the Interscience Conference on Antimicrobial Agents and Chemotherapy held last month in Chicago, and also discussed them with reporters at a recent media briefing.
A 1.6-million-birth analysis finds that adoption of a 2016 trial's antibiotic protocol climbed sharply in US hospitals, with a drop in infection rates.
First approved for adults in 2022, the therapy is now cleared for adults and pediatric patients weighing 66 lbs or more with symptomatic obstructive hypertrophic cardiomyopathy.
With the inherent value medications provide in the greater health care system, Jennifer Hammons, PharmD, DrPH, argues that rural pharmacies deserve the proper recognition.
Community pharmacists offer accessible care, improve medication adherence, and build trust through education, vaccination support, and local health leadership.